MDGL · Madrigal Pharmaceuticals, Inc. · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of MDGL by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 13.54% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 2.44% | 566,002 |
| Index ETFs | 11.10% | 2,578,620 |
| Active ETFs | 0.26% | 60,393 |
| Active funds | 16.19% | 3,761,476 |
| Unclassified | 0.31% | 72,976 |
| All registered funds | 30.30% | 7,039,467 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding MDGL
392 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 584,997 | $314,114,139 | 0.01% | Long | 2026-06-30 | |
| VANGUARD HEALTH CARE FUND | — | 563,117 | $263,155,836 | 0.69% | Long | 2026-07-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 423,142 | $227,206,097 | 0.12% | Long | 2026-06-30 | |
| Janus Henderson Forty Fund | — | 338,602 | $181,812,344 | 0.76% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 243,683 | $130,845,587 | 0.28% | Long | 2026-06-30 | |
| Janus Henderson Enterprise Fund | — | 233,269 | $125,253,790 | 0.56% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 216,882 | $116,454,790 | 0.12% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 211,251 | $113,431,224 | 1.06% | Long | 2026-06-30 | |
| Janus Henderson Contrarian Fund | — | 168,259 | $90,346,670 | 1.65% | Long | 2026-06-30 | |
| VANGUARD EXPLORER FUND | — | 190,140 | $88,856,225 | 0.40% | Long | 2026-07-31 | |
| iShares Biotechnology ETF | IBB | 153,736 | $82,548,545 | 0.91% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 145,364 | $78,053,200 | 1.34% | Long | 2026-06-30 | |
| Invesco Discovery Fund | — | 131,434 | $70,978,303 | 0.96% | Long | 2026-08-31 | |
| Lord Abbett Growth Leaders Fund | — | 140,436 | $65,628,552 | 0.88% | Long | 2026-07-31 | |
| iShares Russell Mid-Cap Growth ETF | IWP | 105,779 | $56,798,034 | 0.26% | Long | 2026-06-30 | |
| Select Biotechnology Portfolio | FBIOX | 98,095 | $52,974,243 | 0.84% | Long | 2026-08-31 | |
| Fidelity Extended Market Index Fund | FSMAX | 92,091 | $49,731,903 | 0.12% | Long | 2026-08-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 89,795 | $48,491,994 | 0.21% | Long | 2026-08-31 | |
| Hood River Small-Cap Growth Fund | — | 86,744 | $46,577,191 | 0.70% | Long | 2026-06-30 | |
| Janus Henderson Triton Fund | — | 81,634 | $43,833,376 | 0.74% | Long | 2026-06-30 | |
| Columbia Small Cap Growth Fund | — | 75,867 | $40,970,456 | 1.16% | Long | 2026-08-31 | |
| iShares Russell Mid-Cap ETF | IWR | 73,533 | $39,483,544 | 0.07% | Long | 2026-06-30 | |
| iShares Russell 1000 Growth ETF | IWF | 68,379 | $36,716,104 | 0.03% | Long | 2026-06-30 | |
| LORD ABBETT DEVELOPING GROWTH FUND INC | — | 71,320 | $33,329,262 | 1.50% | Long | 2026-07-31 | |
| Columbia Cornerstone Growth Fund | — | 71,212 | $33,278,792 | 0.51% | Long | 2026-07-31 | |
| Fidelity Mid Cap Index Fund | FSMDX | 67,846 | $31,705,793 | 0.06% | Long | 2026-07-31 | |
| Small Cap Growth Fund | — | 66,541 | $31,095,940 | 0.56% | Long | 2026-07-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 56,364 | $30,264,650 | 0.25% | Long | 2026-06-30 | |
| Janus Henderson Venture Fund | — | 56,345 | $30,254,448 | 0.84% | Long | 2026-06-30 | |
| Schwab U.S. Mid-Cap ETF | SCHM | 52,295 | $28,240,869 | 0.19% | Long | 2026-08-31 | |
| Artisan Small Cap Fund | — | 47,205 | $25,346,725 | 2.65% | Long | 2026-06-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 45,484 | $24,562,725 | 0.11% | Long | 2026-08-31 | |
| Columbia Select Mid Cap Growth Fund | — | 44,475 | $24,017,834 | 1.04% | Long | 2026-08-31 | |
| Columbia Acorn Fund | — | 40,263 | $21,619,218 | 0.78% | Long | 2026-06-30 | |
| Harbor Small Cap Growth Fund | — | 46,021 | $21,506,534 | 0.81% | Long | 2026-07-31 | |
| ACAP Strategic Fund | — | 39,609 | $21,268,053 | 0.18% | Long | 2026-06-30 | |
| JNL/Invesco Small Cap Growth Fund | — | 38,757 | $20,810,571 | 1.02% | Long | 2026-06-30 | |
| Artisan International Small-Mid Fund | — | 37,662 | $20,222,611 | 0.80% | Long | 2026-06-30 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 38,812 | $19,559,696 | 0.78% | Long | 2026-09-30 | |
| Fidelity Total Market Index Fund | FSKAX | 36,139 | $19,516,144 | 0.01% | Long | 2026-08-31 | |
| Invesco Small Cap Growth Fund | — | 35,492 | $19,057,429 | 1.04% | Long | 2026-06-30 | |
| VALUE LINE LARGER COMPANIES FOCUSED FUND, INC. | — | 35,000 | $18,793,250 | 4.30% | Long | 2026-06-30 | |
| William Blair Small-Mid Cap Growth Fund | — | 36,100 | $18,192,956 | 1.56% | Long | 2026-09-30 | |
| Fidelity Puritan Fund | — | 32,907 | $17,770,767 | 0.05% | Long | 2026-08-31 | |
| Fidelity Enhanced Small Cap Core ETF | FESM | 32,841 | $17,633,975 | 0.30% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 29,531 | $15,947,626 | 0.01% | Long | 2026-08-31 | |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND | — | 29,305 | $15,825,579 | 0.03% | Long | 2026-08-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 29,011 | $15,577,456 | 0.11% | Long | 2026-06-30 | |
| ClearBridge Small Cap Growth Fund | — | 31,954 | $14,932,743 | 0.78% | Long | 2026-07-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 27,588 | $14,898,348 | 0.23% | Long | 2026-08-31 |